It was revealed that CCDC78, CD300LG, CTAG2, DYNLL2, MAPKAPK2, MREG, NME8, PGK2, RALBP1, SIGLEC1, SLC1A1, SLC39A12, TMEM63A, and WRAP73 were significantly associated with the OS rate of DLBCL patients (Figure 2C and Supplementary Figures S1A–S1N). Here, SLC39A12 is linked to diffuse large B-cell lymphoma.